Ammonium Lactate Cream 12% w/w

approved as a new DCGI molecule on 03-12-2010 is indicated for the treatment of dry, scaly skin(xerosis)
and ichthyosis vulgaris and for temporary relief of itching associated with these conditions.

This skin condition is characterized by dry, reddened skin, with fine cracks. This can cause itching and pain. To know the detailed description of the said product, kindly mail to meditextchd@gmail.com.

Temsirolimus Concentrate for Infusion for Injection 25mg/ml

Renal cell carcinoma (RCC, also known as hypernephroma) is a kidney cancer that originates in the lining of the proximal convoluted tubule, the very small tubes in the kidney that filter the blood and remove waste products.
It occurs most often in men ages 50 - 70.
The exact cause is unknown.
The following may increase your risk of kidney cancer:

• Dialysis treatment
• Family history of the disease
• High blood pressure
• Horseshoe kidney
• Polycystic kidney disease
• Smoking
• Von Hippel-Lindau disease (a hereditary disease that affects blood vessels in the brain, eyes, and other body parts)

 

Symptoms

• Abdominal pain and swelling
• Back pain
• Blood in the urine
• Swelling of the veins around a testicle (varicocele)
• Flank pain
• Weight loss

Other symptoms that can occur with this disease:

• Excessive hair growth in females
• Pale skin
• Vision problems

Signs and tests

Physical examination reveals

• Mass or swelling of the abdomen
• A varicocele in the male scrotum

Tests include:

• Abdominal CT scan
• Blood chemistry
• Complete blood count (CBC)
• Intravenous pyelogram (IVP)
• Liver function tests
• Renal arteriography
• Ultrasound of the abdomen and kidney
• Urine tests

The following tests may be done to see if the cancer has spread:

• Abdominal CT scan
• Abdominal MRI
• Bone scan
• Chest x-ray 
• Chest CT scan
• PET scan
  
  Temsirolimus Concentrate for Infusion for Injection 25mg/ml has been approved by DCGI as a new DCGI molecule on 11-12-2010 for the treatment of advanced renal carcinoma. To know more on this new DCGI molecule, kindly mail to meditextchd@gmail.com.
  
  

Clindamycin palmitate HCl for oral solution 75mg/5ml

approved by DCGI as a new molecule on 14-12-2010 indicated for prophylaxis against alphahemolytic(viridans group) sreptococci before dental, oral and upper respiratory tract surgery. Clindamycin, an antimicrobial agent that has been in use worldwide for more than 3 decades, has been consistently effective in the treatment of infections involving a wide spectrum of facultative and strictly anaerobic bacteria. For the details on the same, kindly mail to meditextchd@gmail.com.

Acetyl Cysteine Eye Drops 5% w/v

approved as a new DCGI nolecule on 14-12-2010 indicated for the relief of dry eye symptoms associated
with deficient tear secretion, impaired or abnormal mucus production. 

Dry eye syndrome is a very common condition that is characterized by a disturbance of the tear film. This abnormality may result in disruption of the ocular surface. Dry eye syndrome (DES) -- also called dry eye or keratoconjunctivitis sicca (KCS) -- is a common disorder of the tear film that affects a significant percentage of the population, especially those older than 40 years of age.

• To help keep the eyes comfortable and vision optimal, a normal, thin film of tears coats the eyes. Three main layers make up this tear film.
• The innermost layer is the thinnest. It is a layer of mucin (or mucus). This very thin layer of mucus is produced by the cells in the conjunctiva (the clear skin that lines the eye). The mucus helps the overlying watery layer to spread evenly over the eye.
• The middle (or aqueous) layer is the largest and the thickest. This layer is essentially a very dilute saltwater solution. The lacrimal glands under the upper lids and the accessory tear glands produce this watery layer. The function of this layer is to keep the eye moist and comfortable, as well as to help flush out any dust, debris, or foreign objects that may get into the eye. Defects of the aqueous layer are the most common cause of dry eye syndrome, also referred to as dry eye or keratoconjunctivitis sicca (KCS).
• The most superficial layer is a very thin layer of lipids (fats or oils). These lipids are produced by the meibomian glands and the glands of Zeis (oil glands in the eyelids). The main function of this lipid layer is to help decrease evaporation of the watery layer beneath. 

For details on the same, kindly mail to meditextchd@gmail.com.

Ramelteon film coated tablets 8mg 

approved by DCGI as a new drug on 15-12-2010 for the treatment of insomnia characterized by
difficulty with sleep onset. Insomnia or sleeplessness refers to the individual's report of sleeping difficulties.

Ref.: ^ ^{a b c d e} Roth, Thomas (15 August 2007). "Insomnia: Definition, Prevalence, Etilogy, and Consequences". J Clin Sleep Med 3 (5 Suppl): S7–S10. PMC 1978319. PMID 17824495

Episodes may come and go (episodic), last up to 3 weeks (short-term), or be long-lasting (chronic). While the term is sometimes used in sleep literature to describe a disorder demonstrated by polysomnographic evidence of disturbed sleep.

To know more on the efficacy of Ramelteon tablets in insomniac patients, kinldy mail to meditextchd@gmail.com. We would provide you with the latest study material for the same. In case of the matter required for designing manuals and visual aids required by pharmaceutical companies for their sales promotion, we provide the latest matter with references.

 

 

Memantine hydrochloride ER tablet 7mg/14mg/21mg

is an orally active NMDA receptor antagonist. The chemical name for memantine hydrochloride is 1-amino-3,5-dimethyladamantane hydrochloride. It has demonstrated efficacy and safety in Alzheimer's disease and is
approved for use in the European Union and Australia.
Memantine, a low to moderate affinity NMDA (N-methyl-D-aspartate) receptor antagonist is thought to selectively block the effects associated with abnormal transmission of the neurotransmitter glutamate, while allowing for the physiological transmission associated with normal cell functioning.
The overexcitation of NMDA receptors by the neurotransmitter glutamate may facilitate Alzheimer's disease since glutamate is found in the neural pathways associated with learning and memory. Abnormal levels of glutamate may be responsible for neuronal cell dysfunction and the eventual cell death observed in Alzheimer's disease.

For details on this molecule, mail to meditextchd@gmail.com.

Pyridoxine HCL IP 3mg + Nicotinamide IP 100mg + Cyanocobalamin IP 15mcg + Folic acid IP 500mcg + Chromium Picolinate USP 250mcg Tablet
approved by DCGI on 23-12-2010 for mineral & vitamins deficiency states in adult patients.

For details on this combination, kindly mail to meditextchd@gmail.com.

Chlorhexidine gluconate IP 1%w/v + Ethyl Alcohol IP 61%w/v Solution

approved by DCGI on 29-12-2010 for surgical hand scrub & healthcare personnel hand wash.

For detailed matter on the same, kindly mail to meditextchd@gmail.com.

Rosuvastatin Calcium IP 5mg/10mg + Fenofibrate BP 160mg/160mg tablet  now in new DCGI molecule approved by our honorable DCGI for its additional strength on 29-12-2010. 

The combination shows very good results in patients with hyperlipidaemia.

For details of the research of the combination, kindly mail to meditextchd@gmail.com.